Systemic adverse drug events to topical prostaglandin analogs for treating glaucoma: a retrospective focused pharmacovigilance study
Abstract Background Prostaglandin analogs are first-line treatments for open-angle glaucoma due to their proven efficacy in reducing intraocular pressure. Despite their topical administration, systemic adverse drug Events (ADEs) have been reported. This study investigates the systemic ADEs associate...
Збережено в:
| Автор: | |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
BMC
2024-12-01
|
| Серія: | BMC Ophthalmology |
| Предмети: | |
| Онлайн доступ: | https://doi.org/10.1186/s12886-024-03823-w |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|